51KShares reported · +29K vs prior quarter
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
REGN · NASDAQ · Biotechnology
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Institutions reporting a stake, Q2 2026
1,330
-68 vs Q1 2026
Share of stock reported
91.6M
shares, no single share count to compare with
Change vs Q1 2026
+22K shares
109 new positions, 167 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 1,317 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out); 25 managers also reported puts and 28 managers calls. Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.